NCT01141244 2014-04-10Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed72 enrolled